Patents for A61P 17 - Drugs for dermatological disorders (106,455)
08/2007
08/08/2007CN101011486A Medicine for treating gynecological inflammation disease and its preparation process
08/08/2007CN101011485A Externally used soup for burn and scald
08/08/2007CN101011482A Pharmaceutical compositions for the treatment of acne
08/08/2007CN101011465A Medical ointment for treating chilblain and its preparing process
08/08/2007CN101011463A Use of perilla oil in the preparation of medicament preparation for preventing and treating osteoporosis and skin senescence
08/08/2007CN101011460A Pharmaceutical composition with both depigmenting and whitening effects
08/08/2007CN101011458A Traditional Chinese medicine formulation for treating ulcer
08/08/2007CN101011456A Externally used antiphlogistic anti-allergic medicament stilbene pine cream for skin side effect of cortical hormone
08/08/2007CN101011446A Application of total saponin from platycodon grandiflorum in pharmacy and cosmetic product
08/08/2007CN101011444A Externally used traditional Chinese medicine and its preparing process
08/08/2007CN101011434A Yew podocarpus leaf preparation and its preparation method
08/08/2007CN101011433A Medicinal liquor for treating skin disease and trauma
08/08/2007CN101011431A Traditional Chinese medicine for health preserving and beauty improving
08/08/2007CN101011427A Chinese traditional medicine for treating Cazenave's lupus and sclerodermas
08/08/2007CN101011392A Amino acid composition for enhancing traumatic organism growth factor expression and oxidation resistance function
08/08/2007CN101011058A Disinfectant and/or bactericidal aqueous compositions
08/07/2007US7253341 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
08/07/2007US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
08/07/2007US7253284 Chemical compounds
08/07/2007US7253254 Polypeptide variants with increased heparin-binding capacity
08/07/2007US7253199 Azole derivatives and pharmaceutical compositions containing them
08/07/2007US7253194 Compounds and inhibitors of phospholipases
08/07/2007US7253191 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
08/07/2007US7253187 Heterocyclic inhibitors of ERK2 and uses thereof
08/07/2007US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis.
08/07/2007US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents
08/07/2007US7253155 Combination of a tetra-substituted pyrimidopyrimidine, and a corticosteroid simultaneously or within 14 days of each other
08/07/2007US7252845 Synergistic compositions containing aromatic compounds and terpenoids present in Alpinia galanga
08/07/2007US7252799 Methods for sterilizing preparations containing albumin
08/07/2007CA2376379C Modified chimeric polypeptides with improved pharmacokinetic properties
08/07/2007CA2351536C Therapeutic anti-fungal nail preparation
08/07/2007CA2324001C Retinoid-like compounds for the promotion of melanin production
08/07/2007CA2317589C Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
08/02/2007WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K
08/02/2007WO2007086582A1 OIL-IN-WATER TYPE EMULSION LOTION CONTAINING 22-OXA-1α,25-DIHYDROXYVITAMIN D3 AND METHOD OF TREATING SKIN DISEASE BY USING THE SAME
08/02/2007WO2007086573A1 Agent for preventing or improving disease caused by candida infection and oral composition
08/02/2007WO2007086565A1 Growth hormone secretion regulator
08/02/2007WO2007085681A1 Treatment substance containing magnesium salts for treatment of tumors or like and use of magnesium salts
08/02/2007WO2007085652A1 Use of the (s) enantiomer of mequitazine for preparing a medicament, while at the same time limiting genomic toxicity
08/02/2007WO2007085626A1 Purification and use of a factor for supporting wound healing
08/02/2007WO2007085086A1 A composition including a silicone-based polymer and a method of treating skin disorders using the composition
08/02/2007WO2007068841A3 Use of a composition based on tretinoin, hydroquinone and fluocinolone acetonide, accompanied by a chemical peeling
08/02/2007WO2007065289A3 4-oxo-(iso)tretinoin for the topical treatment of severe dermatological disorders
08/02/2007WO2007059905A3 Thienopyrimidines treating inflammatory diseases
08/02/2007WO2006137100A3 Molecular complex comprising arbutine, ascorbic acid, oleuropeina or its derivatives thereof and related uses in medical field
08/02/2007US20070179297 Chemical compounds
08/02/2007US20070179150 Nitrosated proton pump inhibitors, compositions and methods of use
08/02/2007US20070179118 Use as inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example
08/02/2007US20070179101 biodrug as antitumor agent, a vaccine adjuvant for infections and cancers, and antiallergy agents
08/02/2007US20070179087 Method for treating inflammatory diseases using heat shock proteins
08/02/2007US20070178079 lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood compositions; lactobacilli, bifidobacteria or Enterococci
08/02/2007DE102006004327A1 Chromen-4-on-Derivate Chromen-4-one derivatives
08/02/2007CA2640010A1 Purification and use of a factor for supporting wound healing
08/02/2007CA2637447A1 A composition including a silicone-based polymer and a method of treating skin disorders using the composition
08/01/2007EP1813626A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby
08/01/2007EP1813286A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound
08/01/2007EP1813284A1 Pharmaceutical composition
08/01/2007EP1813278A1 Nucleoside analogs with carboxamidine modified monocyclic base
08/01/2007EP1813269A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO
08/01/2007EP1813250A1 External preparation
08/01/2007EP1812451A2 Compounds and methods of use thereof
08/01/2007EP1812441A1 1,4 substituted pyrazolopyrimidines as kinase inhibitors
08/01/2007EP1812374A1 Novel salts of fumaric acid monoalkylesters and their pharmaceutical use
08/01/2007EP1812034A1 Compositions and methods for inducing melanogenesis in a subject
08/01/2007EP1812029A1 Composition comprising extract of anemarrhena asphodeloides and aralia elata, and use thereof
08/01/2007EP1811990A1 Anti-demodicosis agent
08/01/2007EP1572071A4 Systems and methods for treating patients with processed lipoaspirate cells
08/01/2007EP1546130B1 Piperidine derivatives for use in the treatment of chemokine mediated disease states
08/01/2007EP1507760B1 Cyanoguanidine prodrugs
08/01/2007EP1461326B1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors
08/01/2007EP1419158B1 Pteridinone derivatives as modulators of chemokine receptor activity
08/01/2007EP1393732B1 Minoxidil-containing liquid composition
08/01/2007EP1381681B1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
08/01/2007EP1259235B1 Tyrosine kinase inhibitors
08/01/2007EP1187592B1 Alpha v integrin receptor antagonists
08/01/2007EP1066816B1 Agents promoting laminin production in skin cells
08/01/2007CN1329409C Modulation of the expression of genes dependent on STAT-1
08/01/2007CN1329393C New purine derivatives
08/01/2007CN1329388C 1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors
08/01/2007CN1329374C Compound as CCR5 agonist
08/01/2007CN1329372C Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
08/01/2007CN1329068C Scarless wound healing ointment
08/01/2007CN1329053C Externally applied agent for treating wean hives
08/01/2007CN1329032C Non-sedating barbiturate compounds as neuroprotective agents
08/01/2007CN1329028C Ointment for quick curing trauma of burn and scald
08/01/2007CN1329025C Gels comprising at least one retinoid and benzoyl peroxide
08/01/2007CN101010102A Composition comprising non-oxidizable fatty acid analogoues and plant and/or fish oils
08/01/2007CN101010101A Composition comprising protein material and non-oxidizable fatty acid entities
08/01/2007CN101010084A A composition containing a thiourea derivative for preventing or treating pruritic or irritant skin diseases
08/01/2007CN101010077A Use of targeted oxidative therapeutic formulation in treatment of burns
08/01/2007CN101010076A Immune function-improving agent
08/01/2007CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
08/01/2007CN101007169A A microcapsule of egg yolk immunoglobulin, preparing process and use thereof
08/01/2007CN101007139A An external applied medicine for treating burn and scald
08/01/2007CN101007111A An externally appplied medicine for treating rheumatic diseases
08/01/2007CN101007109A Medicine composition containing metronidazoline
08/01/2007CN101007108A Chinese-western medicine composition containing azelaic acid for treating acne
08/01/2007CN101007107A Composition containing tazarotene
08/01/2007CN101007106A Composition containing tinidazole
08/01/2007CN101007105A Chinese-western medicine composition containing spironolactone